{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:10:28Z","timestamp":1789535428135,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Betty Bamforth Endowment Fund"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL108551"],"award-info":[{"award-number":["R01 HL108551"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbagen.2015.03.011","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T15:37:50Z","timestamp":1428248270000},"page":"1415-1425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298"],"prefix":"10.1016","volume":"1850","author":[{"given":"Uyen B.","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Duellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunting","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2015.03.011_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"5","author":"Pedersen","year":"2004","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0015","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0020","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0025","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.ATV.21.1.122","article-title":"Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering","volume":"21","author":"Wilson","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0735-1097(02)01985-X","article-title":"Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering","volume":"40","author":"Bonetti","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0040","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI10852","article-title":"Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I","volume":"107","author":"Martin","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0045","doi-asserted-by":"crossref","first-page":"26199","DOI":"10.1074\/jbc.M110.103127","article-title":"Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)","volume":"285","author":"Ohnesorge","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0050","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.embor.7400755","article-title":"MAPK signalling: ERK5 versus ERK1\/2","volume":"7","author":"Nishimoto","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0055","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.1093\/emboj\/16.23.7054","article-title":"BMK1\/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C","volume":"16","author":"Kato","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0060","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1128\/MCB.20.22.8382-8389.2000","article-title":"ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain","volume":"20","author":"Kasler","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00109-004-0602-8","article-title":"Role of the BMK1\/ERK5 signaling pathway: lessons from knockout mice","volume":"82","author":"Hayashi","year":"2004","journal-title":"J. Mol. Med. (Berlin)"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0070","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI200419890","article-title":"Targeted deletion of BMK1\/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure","volume":"113","author":"Hayashi","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0075","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1128\/MCB.24.19.8691-8704.2004","volume":"24","author":"Akaike","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI24787","article-title":"Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2","volume":"116","author":"Parmar","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0085","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1182\/blood-2005-08-3465","article-title":"KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium","volume":"107","author":"Dekker","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0090","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/01.RES.0000159707.05637.a1","article-title":"Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function","volume":"96","author":"Lin","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0095","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.20031132","article-title":"KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation","volume":"199","author":"SenBanerjee","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5551\/jat.11.62","article-title":"Global analysis of RNA expression profile in human vascular cells treated with statins","volume":"11","author":"Morikawa","year":"2004","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0105","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0115","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/cb200206w","article-title":"A small-molecule screening strategy to identify suppressors of statin myopathy","volume":"6","author":"Wagner","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0120","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/MCB.26.5.1679-1690.2006","article-title":"Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms","volume":"26","author":"Kondoh","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.febslet.2004.03.120","article-title":"Activation of big MAP kinase 1 (BMK1\/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion","volume":"566","author":"Cameron","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/mus.22056","article-title":"A quick, simple and unbiased method to quantify C2C12 myogenic differentiation","volume":"44","author":"Velica","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0135","doi-asserted-by":"crossref","first-page":"A34","DOI":"10.1161\/res.111.suppl_1.A34","article-title":"Abstract 34: Statins directly activate ERK5 and reduce endothelial dysfunction and acute allograft rejection","volume":"111","author":"Takei","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0140","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-010-0216-5","article-title":"Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide","volume":"27","author":"Shirasaka","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0145","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1074\/jbc.M313465200","article-title":"WNK1 activates ERK5 by an MEKK2\/3-dependent mechanism","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: a review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0005-2736(98)00194-1","article-title":"Effect of cholesteryl hemisuccinate on the interfacial properties of phosphatidylcholine bilayers","volume":"1415","author":"Massey","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0160","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1021\/bi00020a032","article-title":"Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release","volume":"34","author":"Furfine","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/abbi.1993.1578","article-title":"Overexpression, purification, and kinetic characterization of a carboxyl-terminal-truncated yeast squalene synthetase","volume":"307","author":"LoGrasso","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0170","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cbpa.2012.10.015","article-title":"Recent advances in protein prenyltransferases: substrate identification, regulation, and disease interventions","volume":"16","author":"Zverina","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0175","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","article-title":"Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells","volume":"112","author":"Sen-Banerjee","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0180","first-page":"1846","article-title":"GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells","volume":"57","author":"Miquel","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0185","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0190","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bcp.2009.12.007","article-title":"Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy","volume":"79","author":"Mullen","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nbt1387","article-title":"Large-scale chemical dissection of mitochondrial function","volume":"26","author":"Wagner","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0200","first-page":"3940","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity","volume":"117","author":"Hanai","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0205","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.bcp.2013.04.009","article-title":"Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation","volume":"85","author":"Wu","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2008.09.087","article-title":"Identification of pharmacological inhibitors of the MEK5\/ERK5 pathway","volume":"377","author":"Takake","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0215","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1242\/jcs.070516","article-title":"Multiple phosphorylation of ERK5 in mitosis","volume":"123","author":"Diaz-Rodriguez","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0220","doi-asserted-by":"crossref","first-page":"1829-1827","DOI":"10.1016\/j.cellsig.2010.07.010","article-title":"Alternative ERK5 regulation by phosphorylation durig the cell cycle","volume":"22","author":"Inesta-Vaquera","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0225","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.4049\/jimmunol.1400571","article-title":"Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by stains and antimalarial agents","volume":"193","author":"Le NE","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.devcel.2010.12.005","article-title":"ERK5 regulates muscle cell fusion through Klf transcription factors","volume":"20","author":"Sunadome","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0235","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1101\/gad.4.9.1454","article-title":"MyoD family: a paradigm for development?","volume":"4","author":"Olson","year":"1990","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0240","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0960-9822(00)80027-5","article-title":"MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium","volume":"9","author":"Kolodziejczyk","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0245","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1093\/nar\/26.20.4771","article-title":"Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5\/BMK1","volume":"26","author":"Yang","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0250","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bbagen.2015.03.011_bb0255","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1096\/fj.08-128843","article-title":"Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect","volume":"23","author":"Cao","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2015.03.011_bb0260","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1517\/13543784.9.12.2767","article-title":"Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues","volume":"9","author":"Sebti","year":"2000","journal-title":"Expert Opin. Investig. Drugs"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T09:37:30Z","timestamp":1651657050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416515000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0304416515000914"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.03.011","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}